Puma Biotechnology, Inc.
PBYI
$6.07
$0.172.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.39% | -56.47% | 229.28% | 161.77% | 57.36% |
| Total Depreciation and Amortization | 28.87% | -5.42% | -4.99% | -3.49% | -50.12% |
| Total Amortization of Deferred Charges | -42.86% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.99% | -27.02% | -32.62% | -9.97% | -304.39% |
| Change in Net Operating Assets | -699.27% | 76.41% | 445.90% | -141.18% | 89.09% |
| Cash from Operations | -7.61% | -12.22% | 1,271.18% | -67.88% | 49.28% |
| Capital Expenditure | 325.00% | -30.00% | 0.00% | -- | 64.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,072.44% | 90.68% | -1,652.97% | 108.34% | 71.64% |
| Cash from Investing | -1,062.80% | 95.37% | -1,700.00% | 108.02% | 71.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.45% | 0.45% | 0.00% | -- | -- |
| Cash from Financing | -0.01% | -1.33% | 1.15% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,321.37% | -1,097.37% | 12.85% | 21.00% | -14.40% |